ICM Co. Ltd.
🇰🇷South Korea
A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo
- Conditions
- Osteoarthritis, Knee
- Interventions
- Genetic: ICM-203Drug: Placebo
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- ICM Co. Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT05752032
- Locations
- 🇦🇺
Barwon Health, Geelong, Victoria, Australia
🇦🇺Royal Adelaide Hospital, Adelaide, South Australia, Australia
A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.
Phase 1
Not yet recruiting
- Conditions
- Osteoarthritis, Knee
- Interventions
- Genetic: ICM-203
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- ICM Co. Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT05454566
© Copyright 2025. All Rights Reserved by MedPath